Search Results

There are 1618 results for: content related to: Treatment and Prevention of Bone Metastases and Myeloma Bone Disease

  1. You have free access to this content
    Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

    Journal of Bone and Mineral Research

    Volume 30, Issue 1, January 2015, Pages: 3–23, Aliya A Khan, Archie Morrison, David A Hanley, Dieter Felsenberg, Laurie K McCauley, Felice O'Ryan, Ian R Reid, Salvatore L Ruggiero, Akira Taguchi, Sotirios Tetradis, Nelson B Watts, Maria Luisa Brandi, Edmund Peters, Teresa Guise, Richard Eastell, Angela M Cheung, Suzanne N Morin, Basel Masri, Cyrus Cooper, Sarah L Morgan, Barbara Obermayer-Pietsch, Bente L Langdahl, Rana Al Dabagh, K. Shawn Davison, David L Kendler, George K Sándor, Robert G Josse, Mohit Bhandari, Mohamed El Rabbany, Dominique D Pierroz, Riad Sulimani, Deborah P Saunders, Jacques P Brown, Juliet Compston and on behalf of the International Task Force on Osteonecrosis of the Jaw

    Version of Record online : 26 DEC 2014, DOI: 10.1002/jbmr.2405

  2. You have free access to this content
    Zoledronic acid use in cancer patients

    Cancer

    Volume 117, Issue 1, 1 January 2011, Pages: 11–23, Robert Coleman, Richard Cook, Vera Hirsh, Pierre Major and Allan Lipton

    Version of Record online : 31 AUG 2010, DOI: 10.1002/cncr.25529

  3. Bisphosphonates and other bone agents for breast cancer

    Intervention Review

    The Cochrane Library

    Matthew HF Wong, Martin R Stockler and Nick Pavlakis

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD003474.pub3

  4. You have free access to this content
    Bisphosphonates in multiple myeloma: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Rahul Mhaskar, Jasmina Redzepovic, Keith Wheatley, Otavio Augusto Camara Clark, Branko Miladinovic, Axel Glasmacher, Ambuj Kumar and Benjamin Djulbegovic

    Published Online : 16 MAY 2012, DOI: 10.1002/14651858.CD003188.pub3

  5. The use of bisphosphonates in cancer treatment

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 3–14, Robert Coleman

    Version of Record online : 28 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05766.x

  6. Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line

    Cell Proliferation

    Volume 44, Issue 2, April 2011, Pages: 139–146, M. Di Salvatore, A. Orlandi, C. Bagalà, M. Quirino, A. Cassano, A. Astone and C. Barone

    Version of Record online : 15 MAR 2011, DOI: 10.1111/j.1365-2184.2011.00745.x

  7. The use of zoledronic acid in pediatric cancer patients

    Pediatric Blood & Cancer

    Volume 56, Issue 4, April 2011, Pages: 610–614, Keith J. August, Amanda Dalton, Howard M. Katzenstein, Bradley George, Thomas A. Olson, Karen Wasilewski-Masker and Louis B. Rapkin

    Version of Record online : 23 DEC 2010, DOI: 10.1002/pbc.22681

  8. You have free access to this content
    Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid

    Cancer

    Volume 113, Issue 1, 1 July 2008, Pages: 193–201, Allan Lipton, Richard Cook, Fred Saad, Pierre Major, Patrick Garnero, Evangelos Terpos, Janet E. Brown and Robert E. Coleman

    Version of Record online : 5 MAY 2008, DOI: 10.1002/cncr.23529

  9. Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment

    Internal Medicine Journal

    Volume 39, Issue 5, May 2009, Pages: 304–316, M. Dickinson, H. M. Prince, S. Kirsa, A. Zannettino, S. D. J. Gibbs, L. Mileshkin, J. O'Grady, J. F. Seymour, J. Szer, N. Horvath and D. E. Joshua

    Version of Record online : 3 NOV 2008, DOI: 10.1111/j.1445-5994.2008.01824.x

  10. You have free access to this content
    Final 5-year results of Z-FAST trial

    Cancer

    Volume 118, Issue 5, 1 March 2012, Pages: 1192–1201, Adam M. Brufsky, W. Graydon Harker, J. Thaddeus Beck, Linda Bosserman, Charles Vogel, Christopher Seidler, Lixian Jin, Ghulam Warsi, Eliza Argonza-Aviles, John Hohneker, Solveig G. Ericson and Edith A. Perez

    Version of Record online : 10 OCT 2011, DOI: 10.1002/cncr.26313

  11. You have free access to this content
    New and emerging treatments for osteoporosis

    Clinical Endocrinology

    Volume 71, Issue 3, September 2009, Pages: 309–321, Bart L. Clarke

    Version of Record online : 16 FEB 2009, DOI: 10.1111/j.1365-2265.2009.03541.x

  12. You have full text access to this Open Access content
    Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer

    Cancer Science

    Volume 103, Issue 1, January 2012, Pages: 58–66, Ming Zhao, Yohei Tominaga, Kenoki Ohuchida, Kazuhiro Mizumoto, Lin Cui, Shingo Kozono, Hayato Fujita, Ryo Maeyama, Hiroki Toma and Masao Tanaka

    Version of Record online : 7 NOV 2011, DOI: 10.1111/j.1349-7006.2011.02113.x

  13. Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer

    The Prostate

    Volume 73, Issue 5, April 2013, Pages: 500–511, Kohei Hashimoto, Naoya Masumori, Toshiaki Tanaka, Toshihiro Maeda, Ko Kobayashi, Hiroshi Kitamura, Koichi Hirata and Taiji Tsukamoto

    Version of Record online : 19 SEP 2012, DOI: 10.1002/pros.22590

  14. Zoledronic acid and irradiation in oral squamous cell carcinoma

    Journal of Oral Pathology & Medicine

    Volume 44, Issue 2, February 2015, Pages: 103–108, Pia Lopez Jornet, Sanchez Carrillo Susana, Tudela Mulero Rosario and Pons-Fuster Alvaro

    Version of Record online : 24 JUL 2014, DOI: 10.1111/jop.12205

  15. Zoledronate for Metastatic Bone Disease and Pain: A Meta-Analysis of Randomized Clinical Trials

    Pain Medicine

    Volume 14, Issue 2, February 2013, Pages: 257–264, Min Zhu, Rui Liang, Ling-Hui Pan, Bing Huang, Wei Qian, Jian-Hong Zhong, Wei-Wei Zheng and Chang-Long Li

    Version of Record online : 28 DEC 2012, DOI: 10.1111/pme.12016

  16. You have free access to this content
    Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model

    International Journal of Cancer

    Volume 126, Issue 2, 15 January 2010, Pages: 522–532, Penelope D. Ottewell, Diane V. Lefley, Simon S. Cross, C. Alyson Evans, Robert E. Coleman and Ingunn Holen

    Version of Record online : 20 JUL 2009, DOI: 10.1002/ijc.24756

  17. Chapter 85. Treatment and Prevention of Bone Metastases and Myeloma Bone Disease

    Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism

    , Pages: 397–404, 2009

    Published Online : 23 DEC 2009, DOI: 10.1002/9780470623992.ch85

  18. You have free access to this content
    Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases

    Cancer

    Volume 118, Issue 8, 15 April 2012, Pages: 2039–2047, Naoki Niikura, Jun Liu, Naoki Hayashi, Shana L. Palla, Yutaka Tokuda, Gabriel N. Hortobagyi, Naoto T. Ueno and Richard L. Theriault

    Version of Record online : 2 DEC 2011, DOI: 10.1002/cncr.26512

  19. You have free access to this content
    A 55-year-old woman with orbital inflammation

    Arthritis Care & Research

    Volume 64, Issue 11, November 2012, Pages: 1776–1782, Pascale Schwab, David Harmon, Richard Bruno, Frederick W. Fraunfelder and Donna Hyunchung Kim

    Version of Record online : 27 OCT 2012, DOI: 10.1002/acr.21822

  20. Treatment for osteoporosis in people with ß-thalassaemia

    Intervention Review

    The Cochrane Library

    Amit Bhardwaj, Kye Mon Min Swe, Nirmal K Sinha and Ifeyinwa Osunkwo

    Published Online : 10 MAR 2016, DOI: 10.1002/14651858.CD010429.pub2